ReviewJournal of clinical medicine2021

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis.

Kuan-Li Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.